What lessons can we learn from the evaluation of GAEL?

Leprosy Review

Volumn 75, Issue 3, 2004, Pages 214-216

  Durston, T ^a  

^a The Leprosy Mission International   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMBINATION CHEMOTHERAPY; EDITORIAL; EVALUATION; HUMAN; INTERNATIONAL COOPERATION; LEPROSY; LEPROSY CONTROL; MEDICAL RESEARCH; MOTIVATION; MULTIDRUG THERAPY; ORGANIZATION; PREVALENCE;

COMMUNICABLE DISEASE CONTROL; HUMANS; INTERNATIONAL COOPERATION; LEPROSY; PROGRAM EVALUATION; WORLD HEALTH;

EID: 5444253059     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (5)

1. Leprosy Resolution WHA 44.9, Forty-fourth World Health Assembly, 13 May 1991.
2. International Journal of Leprosy Volume 70, No. 1 (supplement) March 2002.
3. Chemotherapy of Leprosy Control Programmes. Report of a WHO Study Group, TRS 675, 1982.
4. Richardus JH, Meima A, Croft RP, Habbema JD. Case detection, gender and disability in leprosy in Bangladesh: a trend analysis. Lepr Rev, 1999; 70: 160-173.
5. COLEP is a prospective sero-epidemiological study on contact transmission and chemoprophylaxis in leprosy. The project is a collaboration with KTT Biomedical Research (Amsterdam, The Netherlands) and the Department of Public Health of the Erasmus University (Rotterdam, The Netherlands), in partnership with the Danish Bangladesh Leprosy Mission (DBLM), funded by The American Leprosy Missions and The Leprosy Mission International. It began in July 2001 and will run to June 2007.